Indian oncology company Venus Remedies has secured marketing authorization from Serbia for its chemotherapy drugs gemcitabine and docetaxel. 20 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.